Chimeric receptors with 4-1BB stimulatory signaling domain
The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.
1. A polynucleotide encoding a chimeric receptor comprising: (a) an extracellular ligand-binding domain; (b) a transmembrane domain; and (c) a cytoplasmic domain comprising a 4-1BB signaling domain and a CD3ζ signaling domain, wherein said extracellular ligand-binding domain specifically targets a cancer of B cell origin.
2. The polynucleotide of claim 1 , wherein said 4-1BB signaling domain comprises amino acid residues 214-255 of SEQ ID NO:2.
3. The polynucleotide of claim 1 , wherein said chimeric receptor further comprises a hinge domain.
4. A vector comprising a polynucleotide encoding a chimeric receptor comprising: (a) an extracellular ligand-binding domain; (b) a transmembrane domain; and (c) a cytoplasmic domain comprising a 4-1BB signaling domain and a CD3ζ signaling domain, wherein said extracellular ligand-binding domain specifically targets a cancer of B cell origin.
5. The vector of claim 4 , wherein said 4-1BB signaling domain comprises amino acid residues 214-255 of SEQ ID NO:2.
6. The vector of claim 4 , wherein said vector is an expression vector, and wherein said polynucleotide is operably linked to at least one regulatory element in the appropriate orientation for expression.
7. The vector of claim 6 , wherein said vector is a viral vector.
8. The vector of claim 6 , wherein said vector is a retroviral vector.
9. The vector of claim 4 , wherein said chimeric receptor further comprises a hinge domain.
10. A host cell comprising a polynucleotide encoding a chimeric receptor comprising: (a) an extracellular ligand-binding domain; (b) a transmembrane domain; and (c) a cytoplasmic domain comprising a 4-1BB signaling domain and a CD3ζ signaling domain, wherein said extracellular ligand-binding domain specifically targets a cancer of B cell origin.
11. The host cell of claim 10 , wherein said 4-1BB signaling domain comprises amino acid residues 214-255 of SEQ ID NO:2.
12. The host cell of claim 10 , wherein said polynucleotide further comprises a promoter sequence.
13. The host cell of claim 10 , wherein said chimeric receptor further comprises a hinge domain.
14. The host cell of claim 10 , wherein said host cell is a T lymphocyte or an NK cell.
15. The host cell of claim 10 , wherein said host cell is a T lymphocyte.
16. The host cell of claim 10 , wherein said host cell is an NK cell.